Alzheimer Society of Canada home page Click here for more information
FrançaisHomeContact Our OfficesE-mail Us

Site Search
Donate Now
About the Society
Alzheimer's Disease
I Have Alzheimer's Disease
Alzheimer Care
Safely Home Registry
Treatment
Research
Current Research
The Next 10 Years
Research Program
Rising Tide
Healthy Brain
Forums
Creative Space

How You Can Help
News and Events
Resources
Media Centre
Site Map

 
 

Research: Current Research
   
 

Dr. Jack Diamond's response to Florida Alzheimer's Disease Research Centre study on caffeine as a viable treatment for Alzheimer's disease

In this section:
Introduction
Research Advances from ICAD
Report: Enhancing Quality of Life for People Living with Dementia
Response to study on caffeine as a viable treatment for Alzheimer's disease
Lowering dementia risk in women
Conference on Clinical Trials on Alzheimer's Disease
Ginkgo biloba study
An Update on Stem Cell Research
Health Canada Approval of Exelon™ Patch
A Report on Alzheimer's Disease and Current Research
Report on Deep Brain Stimulation
Report on Enbrel Study
Comment on Beta-Amyloid
Use of Vaccines for Treating Alzheimer's Disease
Report on Dimebon

In a new study conducted by the Florida Alzheimer's Disease Research Centre (http://hscweb3.hsc.usf.edu/health/now/?p=6700), researchers administered caffeine --the equivalent of humans consuming five cups a day-- to mice genetically engineered to develop human-like symptoms of Alzheimer's disease. Their findings revealed that these mouse models, as in humans, showed abnormally high levels of the beta-amyloid protein in both the brain and blood that are largely responsible for causing memory and thinking impairment in people with Alzheimer's disease.

In the caffeine-treated Alzheimer mice, their findings showed that the beta-amyloid levels were significantly reduced to more normal values. The studies also revealed that the behaviour of these mice resembled that of normal animals. Interestingly, however, the same treatment did not improve the memory or thinking ability of normal mice.

So, should people showing signs of Alzheimer's disease drink five cups of coffee a day? The Research Centre hopes to extend their studies to humans. But given the potential health risks of caffeine, the Alzheimer Society of Canada recommends a wait-and-see approach until results of the human trials are available. It is also important to keep in mind that findings in mouse models do not always translate to humans, though some effects can be replicated. If caffeine can reduce Alzheimer symptoms in humans, we need to know whether this improvement could be offset by other effects of caffeine such as exacerbations of diabetes, tumour growth in the female reproductive system, increased risk of strokes in people with high blood pressure and sleep disorders.

Even if human trials prove successful, the Alzheimer Society advises that anyone diagnosed with Alzheimer's disease or Mild Cognitive Impairment (often a precursor to Alzheimer's disease), should consult their family physician first before increasing their daily dose of coffee.

Back to top

 
Help for Today. Hope for Tomorrow.
Alzheimer Society | Alzheimer's Disease | I Have Alzheimer's Disease
 
Alzheimer Care | Safely Home | Treatment | Research | Healthy Brain
Forums | Creative Space | How You Can Help | News and Events
Resources | Media Centre | Site Map |
Search
Home | Français | Contact Our Offices | E-mail Us
 

Current Research : Intro
About Dr. Jack Diamond
| The Researchers
Brain Changes with Alzheimer's Disease | Drug Treatments
Other Leads for Earlier Diagnosis and New Treatments
Caregiving and Brain Repair | Social & Psychological Research
Download Full Report (PDF)

 

This page last reviewed/revised July 2009.
© Alzheimer Society of Canada 1997-2010. All rights reserved.
Important Notice and Disclaimer
For comments, suggestions or additional information, contact research@alzheimer.ca.